UP!
 |
|
|
Type
|
Public |
|---|---|
| Traded as | NYSE: HCP S&P 500 Component |
| Industry | Real estate investment trust |
| Founded | 1985 |
| Headquarters | Long Beach, California |
|
Key people
|
Tom Herzog, CEO Justin Hutchens, President Michael McKee, Executive Chairman Eduard J. Henning, Esq., General Counsel |
| Revenue |  $2,266.28 million USD (2014) |
|
Operating income
|
$1,322.36 million USD (2014) |
|
Net income
|
$922.23 million USD (2014) |
|
Number of employees
|
N/A |
| Website | http://www.hcpi.com |
HCP, Inc., formerly Healthcare Property Investors Inc., is a Real Estate Investment Trust, invests primarily in real estate serving the United States healthcare industry.
In December 2016, Board of Directors elected Tom Herzog as Chief Executive Officer (CEO) and as a member of the Board. HCP's Board also elected Justin Hutchens as President. Both elections were effective as of January 2017.
Tom Herzog previously served as Chief Financial Officer (CFO) since rejoining the HCP in June 2016, and also served as the HCP's CFO from 2009 to 2011. He will report to Mike McKee, HCP's Executive Chairman. Justin Hutchens will report to Mr. Herzog.
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2023 | 2023-01-06 | Future report Set alerts | |
| Q2 2023 | 2022-09-01 | -0.17 | -0.17 |
| Q1 2023 | 2022-06-02 | -0.17 | -0.17 |
| Q1 2020 | 2022-06-02 | -0.17 | -0.17 |
| Q4 2022 | 2022-03-10 | -0.24 | -0.24 |
| Q4 2019 | 2022-03-10 | 0.00 | 0.00 |
| Q3 2019 | 2019-10-30 | 0.00 | -0.09 |
| Q2 2019 | 2019-07-31 | -0.03 | -0.03 |
| Q1 2019 | 2019-05-01 | 0.13 | 0.13 |
| Q4 2018 | 2019-02-13 | 1.73 | 1.73 |
| 2016-07-12 | Reiterated Rating | Mizuho | Hold | |
| 2016-07-08 | Upgrade | Goldman Sachs Group Inc. | Sell to Neutral | $26.00 to $36.00 |
| 2016-07-06 | Reiterated Rating | Jefferies Group | Hold to Neutral | |
| 2016-06-22 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $32.00 |
| 2016-06-20 | Reiterated Rating | BMO Capital Markets | Sell | |
| 2016-06-15 | Reiterated Rating | Argus | Hold | |
| 2016-06-01 | Downgrade | Barclays | Equal Weight to Underweight | $40.00 to $37.00 |
| 2016-06-01 | Downgrade | Barclays PLC | Equal Weight to Underweight | $40.00 to $37.00 |
| 2016-05-16 | Boost Price Target | Citigroup Inc. | Neutral | $31.00 to $34.00 |
| 2016-05-10 | Reiterated Rating | BMO Capital Markets | Sell | |
| 2016-05-10 | Upgrade | Jefferies Group | Underperform to Hold | $25.00 to $32.00 |
| 2016-04-07 | Boost Price Target | Jefferies Group | $25.00 | |
| 2016-03-28 | Reiterated Rating | Goldman Sachs | Sell | |
| 2016-03-28 | Reiterated Rating | Goldman Sachs Group Inc. | Sell | |
| 2016-03-21 | Boost Price Target | Evercore ISI | $32.00 | |
| 2016-03-16 | Reiterated Rating | JPMorgan Chase & Co. | Hold | |
| 2016-03-15 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $39.00 to $35.00 |
| 2016-03-10 | Lower Price Target | Barclays | Underweight | $37.00 to $33.00 |
| 2016-03-03 | Boost Price Target | Mizuho | Neutral | $26.00 to $32.00 |
| 2016-02-11 | Reiterated Rating | Bank of America | Underperform | $36.50 to $30.00 |
| 2016-02-11 | Downgrade | Stifel Nicolaus | Hold to Sell | $23.00 |
| 2016-02-11 | Reiterated Rating | Bank of America Corp. | Underperform | $36.50 to $30.00 |
| 2016-02-10 | Lower Price Target | Mizuho | Neutral | $37.00 to $26.00 |
| 2016-02-10 | Lower Price Target | Evercore ISI | Hold | $39.00 to $31.00 |
| 2016-02-10 | Lower Price Target | BMO Capital Markets | Underperform | $27.00 |
| 2016-02-10 | Downgrade | Hilliard Lyons | Buy | |
| 2016-01-12 | Downgrade | Jefferies Group | Hold to Underperform | $39.00 to $30.00 |
| 2016-01-06 | Downgrade | Barclays | Equal Weight to Underweight | $40.00 to $37.00 |
| 2016-01-04 | Downgrade | Argus | Buy to Hold | |
| 2015-12-17 | Lower Price Target | Cowen and Company | Market Perform | $40.00 to $39.00 |
| 2015-11-06 | Lower Price Target | RBC Capital | Underperform | $39.00 to $37.00 |
| 2015-11-06 | Lower Price Target | Royal Bank Of Canada | Underperform | $39.00 to $37.00 |
| 2015-11-04 | Lower Price Target | BMO Capital Markets | $38.50 to $36.00 | |
| 2015-11-04 | Lower Price Target | Barclays | Equal Weight | $44.00 to $40.00 |
| 2015-11-02 | Downgrade | Mizuho | Neutral to Underperform | $49.00 to $37.00 |
| 2015-10-26 | Lower Price Target | Mizuho | $41.00 to $37.00 | |
| 2015-09-24 | Reiterated Rating | Argus | Buy | $43.00 to $38.56 |
| 2015-09-21 | Reiterated Rating | Mizuho | Neutral | $39.00 to $41.00 |
| 2015-09-21 | Downgrade | Goldman Sachs | Neutral to Sell | $40.00 to $38.00 |
| 2015-09-08 | Reiterated Rating | Evercore ISI | Hold | $42.00 to $39.00 |
| 2015-09-08 | Lower Price Target | Evercore Partners Inc. | Hold | $42.00 to $39.00 |
| 2015-08-12 | Upgrade | Hilliard Lyons | Neutral to Buy | |
| 2015-07-23 | Reiterated Rating | Citigroup Inc. | Neutral | |
| 2015-06-25 | Reiterated Rating | Argus | Buy | $49.00 to $43.00 |
| 2015-06-12 | Upgrade | Mizuho | Underperform to Neutral | $37.00 to $39.00 |
| 2015-06-11 | Lower Price Target | Argus | Buy | $49.00 to $43.00 |
| 2015-06-09 | Reiterated Rating | Evercore ISI | Hold | $45.00 to $43.00 |
| 2015-06-08 | Reiterated Rating | Jefferies Group | Hold | $46.00 to $40.00 |
| 2015-05-10 | Reiterated Rating | Barclays | Equal Weight | $47.00 to $44.00 |
| 2015-05-06 | Lower Price Target | BMO Capital Markets | Underperform | $40.00 to $38.00 |
| 2015-05-06 | Lower Price Target | RBC Capital | Underperform | $40.00 to $38.00 |
| 2015-04-08 | Initiated Coverage | BMO Capital Markets | Underperform | $42.00 |
| 2015-02-25 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $50.00 to $45.00 |
| 2015-02-10 | Downgrade | Mizuho | Neutral to Underperform | $49.00 to $37.00 |
| 2015-01-26 | Downgrade | Mizuho | Buy to Neutral | $50.00 to $49.00 |
| 2015-01-14 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
| 2015-01-14 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2015-01-08 | Boost Price Target | Barclays | Equal Weight | $45.00 to $47.00 |
| 2014-12-19 | Boost Price Target | Argus | Buy | $46.00 to $49.00 |
| 2014-12-09 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $43.00 to $44.00 |
| 2014-11-18 | Boost Price Target | Mizuho | Buy | $48.00 to $50.00 |
| 2014-11-13 | Upgrade | Morgan Stanley | Equal Weight to Overweight | |
| 2014-10-21 | Downgrade | Jefferies Group | Buy to Hold | $47.00 to $45.00 |
| 2014-10-06 | Initiated Coverage | Evercore ISI | Neutral | $42.00 |
| 2014-08-05 | Boost Price Target | RBC Capital | Outperform | $23.00 to $25.00 |
| 2014-07-23 | Initiated Coverage | Mizuho | Buy | |
| 2014-07-22 | Boost Price Target | Jefferies Group | Buy | $45.00 to $47.00 |
| 2014-06-20 | Boost Price Target | Cowen and Company | $41.00 to $42.00 | |
| 2014-05-12 | Boost Price Target | RBC Capital | $38.00 to $40.00 | |
| 2014-05-07 | Reiterated Rating | Citigroup Inc. | Equal Weight | $39.00 to $42.00 |
| 2014-01-09 | Upgrade | Jefferies Group | Hold to Buy | $43.00 to $41.00 |
| 2014-01-08 | Lower Price Target | Barclays | Equal Weight | $49.00 to $39.00 |
| 2013-11-19 | Downgrade | Stifel Nicolaus | Buy to Hold | $48.00 |
| 2013-10-30 | Reiterated Rating | RBC Capital | Hold | $38.00 |
| 2013-10-30 | Lower Price Target | Barclays | Equal Weight | $52.00 to $49.00 |
| 2013-10-04 | Reiterated Rating | JPMorgan Chase & Co. | Hold | $45.00 |
| 2013-10-04 | Lower Price Target | RBC Capital | Hold | $49.00 to $38.00 |
| 2013-10-03 | Downgrade | RBC Capital | Sector Perform to Underperform | |
| 2013-09-23 | Reiterated Rating | Cowen and Company | Hold | $41.00 |
| 2013-09-23 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $49.00 to $45.00 |
| 2013-09-18 | Lower Price Target | Jefferies Group | Hold | $46.00 to $43.00 |
| 2013-03-18 | Reiterated | Argus | Buy | $52 to $54 |
| 2012-02-14 | Downgrade | Hilliard Lyons | Neutral to Underperform | |
| 2011-08-09 | Upgrade | Hilliard Lyons | Underperform to Neutral | |
| 2010-12-15 | Upgrade | Robert W. Baird | Neutral to Outperform | $32 to $37 |
| 2010-08-18 | Upgrade | Argus | Hold to Buy | $39 |
| 2010-05-24 | Upgrade | Robert W. Baird | Underperform to Neutral | $30 |
| 2010-03-18 | Downgrade | Robert W. Baird | Neutral to Underperform | |
| 2010-03-15 | Downgrade | Jefferies & Co | Buy to Hold | $31 |
| 2010-02-16 | Upgrade | Jefferies & Co | Hold to Buy | $32 to $31 |
| 2010-01-13 | Initiated | Jefferies & Co | Hold | $32 |
| 2016-07-12 | Reiterated Rating | Mizuho | Hold | |
| 2016-07-08 | Upgrade | Goldman Sachs Group Inc. | Sell to Neutral | $26.00 to $36.00 |
| 2016-07-06 | Reiterated Rating | Jefferies Group | Hold to Neutral | |
| 2016-06-22 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $32.00 |
| 2016-06-20 | Reiterated Rating | BMO Capital Markets | Sell |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HCP 178 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 18.08M |
| BlackRock Fund Advisors | 15.18M |
| Shinko Asset Management Co., Ltd. | 14.35M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.07M |
| BlackRock Group LTD | 7.44M |
| JPMORGAN CHASE & CO | 6.43M |
| BAILLIE GIFFORD & CO | 5.58M |
| Capital Research Global Investors | 5.21M |
| Standard Life Investments LTD | 4.38M |
| COHEN & STEERS CAPITAL MANAGEMENT INC | 3.97M |
| Vanguard Group, Inc | 3.19M |
| TEACHERS ADVISORS INC | 3.01M |
| FRANKLIN RESOURCES INC | 2.96M |
| MANAGED ACCOUNT ADVISORS LLC | 2.73M |
| RUSSELL FRANK CO/ | 2.31M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| FLAHERTY JAMES F III Chairman, Pres. and CEO | 0.19% (861753) | HCP / |
| ROATH KENNETH B | 0.05% (241013) | HCP / |
| Brinker Scott M EVP and CIO | 0.05% (228000) | HCN / HCP / |
| GALLAGHER PAUL F EVP and CIO | 0.05% (224271) | HCP / |
| Klaritch Thomas Executive Vice President | 0.04% (173748) | HCP / |
| HERZOG THOMAS M EVP and CFO | 0.03% (134775) | HCP / UDR / |
| Scott Peter A Chief Financial Officer | 0.02% (108938) | HCP / |
| Schoen Timothy M EVP and CFO | 0.02% (96377) | HCP / |
| MARTIN LAURALEE | 0.02% (87605) | ABM / HCP / JLL / KALU / |
| SULLIVAN JOSEPH P | 0.02% (74173) | CI / HCP / |
| Mercer James W EVP,Gen Counsel and Corp Sec | 0.01% (68286) | HCP / |
| Young Kendall K Executive Vice President | 0.01% (62544) | HCP / |
| Hoffmann James P | 0.01% (53544) | FPO / HCP / |
| MCKEE MICHAEL D | 0.01% (53225) | FAF / HCP / MBG / O / |
| HENRY DAVID | 0.01% (48891) | ARCP / CXP / HCP / KIM / SKT / |
| Bergschneider Jonathan M. Executive Vice President | 0.01% (44366) | HCP / |
| Kirby Thomas D Executive Vice President | 0.01% (40481) | HCP / |
| Tate Susan M Executive Vice President | 0.01% (40098) | HCP / |
| Hutchens James Justin EVP and CIO - Sr Housing/Care | 0.01% (37038) | HCP / NHI / |
| McHenry Troy E. Executive Vice President | 0.01% (34121) | HCP / |
| HENNING EDWARD J Executive Vice President | 0.01% (33928) | HCP / |
| Lu Lihpang Executive Vice President | 0.01% (29789) | HCP / |
| Anderson Scott A SVP and CAO | 0.01% (27345) | HCP / |
| Stasinos John D. Executive Vice President | 0.01% (23539) | HCP / |
UM